Showing results (141-150 of 2,811) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|February 14, 2006
Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetesM Orsini-Federici, J Akwe Akwi, V Canonico, et al.
Diabetes Technology & Therapeutics|May 14, 2008
Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysisRoger S Mazze, Ellie Strock, David Wesley, et al.
Diabetes Technology & Therapeutics|May 14, 2008
The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditionsEfstrathios Karagiannis, Andreas Pfützner, Thomas Forst, et al.
Diabetes Technology & Therapeutics|April 10, 2025
Significant Hyperglycemia in Hospitalized Total Pancreatectomy Patients: Results of a Pilot Prospective Continuous Glucose Monitoring StudyShafaq R Rizvi, Ayan Bannerjee, Ravinder J Kaur, et al.
Diabetes Technology & Therapeutics|April 2, 2025
Continuous Glucose Monitoring-Measured Glucose Levels During Oral Glucose Tolerance Testing in PregnancyAnders L Carlson, Roy W Beck, Zoey Li, et al.
Diabetes Technology & Therapeutics|April 29, 2025
Blood Glucose Prediction Algorithms Require Clinically Relevant Performance Criteria Beyond AccuracyMiriam K Wolff, Hans Georg Schaathun, Sebastien Gros, et al.
Diabetes Technology & Therapeutics|April 21, 2025
Accuracy of FreeStyle Libre 3 During Moderate-Intensity Continuous Aerobic Exercise at Different Phases of the Menstrual Cycle in Females with Type 1 DiabetesAlba Cuerda-Del Pino, Alejandro José Laguna Sanz, José-Luis Díez, et al.
Diabetes Technology & Therapeutics|May 30, 2025
Fully Closed-Loop Improves Glycemic Control Compared with Pump with CGM in Adolescents with Type 1 Diabetes and HbA1c Above Target: A Two-Center, Randomized Crossover StudyNithya Kadiyala, Rama Lakshman, Janet Allen, et al.
Diabetes Technology & Therapeutics|May 30, 2025
Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational StudyAlexandros L Liarakos, Thomas S J Crabtree, Tomás P Griffin, et al.
Diabetes Technology & Therapeutics|June 2, 2025
Does the OP5 Automated Insulin Delivery System Close the Gap in Glycemic Control Between White and Black Youth with Type 1 Diabetes?Risa M Wolf, Dhruva Patel, Sonia Gera, et al.
Pageof 282